Janice Lima Maribona, DO
Dermatology · Miami, FLNPI 1649292194
Payments from drug & device makers
Across 509 payments — averaging $1076.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$201K
- Sun Pharmaceutical Industries Inc.$189K
- Teva Pharmaceuticals USA, Inc.$99K
- Taro Pharmaceuticals USA, Inc.$43K
- Galderma Laboratories, L.p.$7K
- Promius Pharma LLC$2K
- plus $6K from 22 others
What the payments were for
- Consulting fees$5,3502%
- Speaking & faculty fees$191,66688%
- Travel & lodging$8,4834%
- Food & beverage$11,0845%
- Education$1540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 147 | $200,833 |
| Sun Pharmaceutical Industries Inc. | 21 | $189,281 |
| Teva Pharmaceuticals USA, Inc. | 13 | $99,313 |
| Taro Pharmaceuticals USA, Inc. | 7 | $42,969 |
| Galderma Laboratories, L.p. | 192 | $7,143 |
| Promius Pharma LLC | 4 | $2,156 |
| LEO Pharma Inc. | 18 | $1,320 |
| Medimetriks Pharmaceuticals, Inc. | 4 | $1,167 |
| Revance Therapeutics, Inc. | 19 | $939 |
| Merz North America, Inc. | 14 | $814 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 15 | $684 |
| Incyte Corporation | 3 | $215 |
| Pfizer | 11 | $215 |
| Regeneron Healthcare Solutions, Inc. | 3 | $151 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| VYNE Pharmaceuticals Inc. | 4 | $121 |
| ANI Pharmaceuticals, Inc. | 5 | $121 |
| Journey Medical Corporation | 5 | $110 |
| Johnson & Johnson | 2 | $107 |
| Mayne Pharma Commercial LLC | 5 | $79 |
| Organon | 5 | $78 |
| Solta Medical, A Division Of Bausch Health US, LLC | 3 | $60 |
| Biofrontera Inc. | 2 | $34 |
| Almirall LLC | 2 | $30 |
| Triad Life Sciences Inc. | 1 | $29 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Dermira, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$119,792
- Promiseb Complete$2,137
- Sernivo$2,137
- TRIANEX 0.05%$2,137
- KYBELLA$1,950
- Genadur$1,150
- Neo-Synalar$1,150
- ADBRY$362
- DAXXIFY$209
- BOTOX COSMETIC$132
- OPZELURA$125
- ANZUPGO$125
- Tremfya$125
- SILIQ$108
- DUPIXENT$103
- XEOMIN$101
- ASCLERA$101
How this compares
$548,149 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 16 | $896 |
| Clindamycin Phosphate | 20 | $785 |
| Ketoconazole | 50 | $744 |
| Ciclopirox | 18 | $492 |
| Fluticasone Propionate | 12 | $378 |
| Triamcinolone Acetonide | 24 | $309 |
| Mometasone Furoate | 17 | $258 |
| Hydrocortisone | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Miami
- Hector Wiltz JrMiami$6.4M
- Francisco KerdelMiami$5.1M
- Jill WaibelMiami$4.3M
- Gil YosipovitchMiami$3.7M
- Mercedes GonzalezMiami$3.6M
- Giovanna CioccaMiami$3.2M
- David RodriguezMiami$3M
- Hadar Lev-TovMiami$2.5M
- Leslie BaumannMiami$2.3M
- Mojgan HosseinipourMiami$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.